EP2654755
Combination therapy comprising Gemcitabine for the treatment of pancreatic cancer
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
20.12.2011EP published:
17.8.2016EP application number:
11851046.0
EPO information:
European Patent Register
Max expiry date:
19.12.2031
Title:
Combination therapy comprising Gemcitabine for the treatment of pancreatic cancer
Timeline
Today
20.12.2011EP application
17.8.2016EP Publication
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
DEMARINI, Douglas, J.Address:
CollegevillePA, US
Name:
LE, Ngocdiep, T.Address:
CollegevillePA, US
Priority
Number:
201061424961 PDate:
20.12.2010Country:
US
Classification
Categories:
A61K 31/519, A61K 31/7068, A61K 9/00, A61P 35/00, A61K 9/20, A61K 9/48